Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Where is biological therapy going?

H Schulze-Koops1, J R Kalden

  • 1Department of Internal Medicine III, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. schulze-koops@med3.imed.uni-erlangen.de

Arthritis Research
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Position paper of the German Society of Rheumatology e.V. (DGRh) regarding the situation of advanced training in the discipline of rheumatology in Germany].

Zeitschrift fur Rheumatologie·2023
Same author

[Development of quality standards for patients with rheumatoid arthritis for use in Germany].

Zeitschrift fur Rheumatologie·2021
Same author

[Development of quality standards for patients with axial spondyloarthritis for use in Germany].

Zeitschrift fur Rheumatologie·2021
Same author

[Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients].

Zeitschrift fur Rheumatologie·2021
Same author

[Future of acute inpatient rheumatology in Germany : Statement of the Boards of the German Society for Rheumatology and the Association of Rheumatological Acute Clinics on hospital planning North-Rhine/Westphalia 2019 for the discipline rheumatology].

Zeitschrift fur Rheumatologie·2020
Same author

Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatology.

Zeitschrift fur Rheumatologie·2020
Same journal

21st European workshop for rheumatology research.

Arthritis research·2014
Same journal

21st European Workshop for Rheumatology Research, Vienna, Austria, 1-4 March 2001. Abstracts.

Arthritis research·2005
Same journal

Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study.

Arthritis research·2002
Same journal

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.

Arthritis research·2002
Same journal

VLA-4-dependent and -independent pathways in cell contact-induced proinflammatory cytokine production by synovial nurse-like cells from rheumatoid arthritis patients.

Arthritis research·2002
Same journal

Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.

Arthritis research·2002
See all related articles

Biological therapies offer targeted treatment for autoimmune diseases by leveraging molecular biology insights. While effective for symptom management, they haven't yet achieved a permanent cure for chronic immune responses.

Area of Science:

  • Molecular and cellular biology
  • Immunology
  • Pharmacology

Background:

  • Advances in molecular and cellular biology enable the design of targeted biological therapeutics.
  • Biologicals have enhanced understanding of autoimmune disease pathogenesis.
  • Current biological therapies manage chronic inflammation symptoms but do not permanently resolve immune responses.

Purpose of the Study:

  • To discuss current concepts and future directions in biological therapy for autoimmune diseases.
  • To explore the potential of biologicals in specific critical applications for treating human autoimmune diseases.

Main Methods:

  • Commentary and discussion of existing research and concepts.
  • Analysis of current biological therapy approaches.
  • Exploration of future directions and potential applications.

Related Experiment Videos

Main Results:

  • Biologicals are valuable tools for understanding autoimmune disease mechanisms.
  • Existing biological therapies show success in managing inflammatory symptoms.
  • Permanent silencing of chronic immune responses remains an unmet goal for current biologicals.

Conclusions:

  • Biological therapy holds promise for autoimmune diseases when appropriately designed and applied.
  • Future research should focus on developing agents for critical applications to achieve more definitive outcomes.
  • Optimizing biological agents is key to meeting the expectations of permanently controlling autoimmune conditions.